>>> US Gapping up

Gapping up
In reaction to earnings/guidance:
  • BLSM +1.8%
Other news:
  • NHIC +5.0% (Shareholders approved the newcleo business combination, with closing anticipated September 21 and Nasdaq trading expected September 22.)
  • BWMX +4.9% (Disclosed insider purchases totaling about $2.3 million by the CEO, chairman and a director.)
  • CAVA +4.7% (Authorized a $100 million share repurchase program through September 17, 2027.)
  • INTA +4.1% (Launched a Celeste plug-in for ChatGPT Enterprise, bringing governed AI tools into law firms' OpenAI workflows.)
  • BTGO +3.6% (Appoints Alex Rozman chief compliance officer, effective Sept. 21.)
  • RTB +3.1% (Agreed to acquire 49.5% of Paradium.AI at $3.80 per share and enter a 10-year platform agreement.)
  • TMCI +3.1% (Reported five-year Lapiplasty study data showing low recurrence and sustained patient-reported improvement.)
  • MG +2.6% (Agreed to be acquired by H.I.G. Capital for $20.35 per share in cash, valuing the deal at $866 million.)
  • USAS +2.4% (Reported high-grade silver-copper-lead-antimony drill results and new vein discoveries at the Galena Complex.)
  • ESLT +1.6% (Filed a two-year Israeli shelf prospectus for potential debt or equity offerings, with no issuance terms decided.)
  • COHR +1.6% (Expanded its optical systems portfolio with a full C-band amplifier for 800G AI datacenter networks, shipping in volume.)
  • SCZM +1.6% (Completed acquisition of a 500-tonne-per-day Bolivian milling facility, targeting commercial production by year-end after a $14 million investment.)
  • MOD +1.5% (Set Sept. 28 as record date for Performance Technologies spin-off and Gentherm merger, expected to close Oct. 1.)
  • BUR +1.5% (Closes $300 million debt raise, enabling early redemption of $400 million notes and reducing total debt by $100 million.)
  • INCY +1.5% (Received a positive CHMP opinion for Povofortay to treat active moderate-to-severe hidradenitis suppurativa in adults.)
  • SKHY +1.4% (Launched SK hynix Ventures to expand investments and technology partnerships across AI computing and data-center infrastructure.)
  • INTC +1.3% (Is reportedly in exploratory talks with SK hynix over potential U.S. chip production.)
  • HDSN +1.2% (Signs joint development agreement with Icorium to commercialize patented refrigerant separation technology.)
  • AZN +1.1% (Received FDA Priority Review for efzimfotase alfa in hypophosphatasia, with a decision expected in first-half 2027.)